Skip to main content

Advertisement

Log in

A clinical case series of six extremely aggressive youths treated with olanzapine

  • CASE REPORT
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract.

Olanzapine is an atypical neuroleptic drug with mood-stabilising properties and few of the side effects commonly associated with conventional neuroleptic treatment. We used olanzapine, 5-20 mg/day, to treat severe aggression in six non-psychotic teenage boys with neuropsychiatric disorders. All but one started to respond within one week. The therapeutic effect in four of the patients clearly outweighed the side effects (weight gain and sedation). The subjects described a markedly increased sense of well being during the olanzapine treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Accepted: 17 November 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soderstrom, H., Rastam, M. & Gillberg, C. A clinical case series of six extremely aggressive youths treated with olanzapine. European Child & Adolescent Psychiatry 11, 138–141 (2002). https://doi.org/10.1007/s00787-002-0265-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-002-0265-3

Navigation